HAP Trading’s Zevra Therapeutics ZVRA Stock Holding History

HAP Trading’s Portfolio ZVRA Stock Details ZVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-23,733	Closed	-$212K	–	2911
2021 Q3	$221K	Buy	+23,733	New	+$239K	0.01%	992

Other funds holding ZVRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

RPCONE

Retirement Planning Company of New England Warwick, Rhode Island $278M AUM 38.65% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

HAP Trading's ZVRA Position: Q4 2021 in Review

HAP Trading sold out of Zevra Therapeutics (ZVRA) in Q4 2021, closing a stake of 23,733 shares — an estimated $212K sold.

HAP Trading first reported a position in ZVRA in Q3 2021 and held it in 1 quarter. The position peaked at $221K in Q3 2021. 77 funds tracked by Wall St. Rank hold ZVRA as of Q4 2021.

HAP Trading reported no remaining Zevra Therapeutics position as of Q4 2021 after selling out during the quarter.
HAP Trading sold 23,733 Zevra Therapeutics shares in Q4 2021, an estimated $212K.
HAP Trading first reported a position in Zevra Therapeutics in Q3 2021 and held it in 1 quarter.
HAP Trading's Zevra Therapeutics position peaked at $221K in Q3 2021.
77 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.